Laboratory assessment of liver function in people starting antiretroviral therapy with Dolutegravir or Efavirenz: a cohort study in Belo Horizonte, Brazil. RSD [Internet]. 2022 Sep. 28 [cited 2025 Dec. 5];11(13):e74111335082. Available from: https://rsdjournal.org/rsd/article/view/35082